[Back to Issue 11 ToC] [Back to Journal Contents] [Back to Biochemistry (Moscow) Home page]

REVIEW: Mutations in Mitochondrial DNA and Approaches for Their Correction

M. V. Patrushev1,2, P. A. Kamenski1,2*, and I. O. Mazunin2*

1Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia; fax: +7 (495) 939-4309; E-mail: peter@protein.bio.msu.ru

2Immanuel Kant Baltic Federal University, Alexander Nevsky str. 14, 236038 Kaliningrad, Russia; fax: +7 (4012) 595-595; E-mail: IMazunin@kantiana.ru

* To whom correspondence should be addressed.

Received June 30, 2014; Revision received August 14, 2014
Apart from the nucleus, the mitochondrion is the only organelle of an animal cell that contains its own genome. Mitochondrial DNA is much less in size than the nuclear one and codes for only several dozens of biological macromolecules. Nevertheless, mutations in mitochondrial genes often result in the occurrence of serious hereditary neuromuscular diseases. New mitochondrial DNA mutations and their relations to clinical symptoms are continuously reported in the scientific literature. In this review, we summarize existing data about such mutations, and also about contemporary gene therapy approaches that have been developed for their suppression.
KEY WORDS: mitochondrial genome, mitochondrial DNA, mutations, mitochondrial diseases, gene therapy

DOI: 10.1134/S0006297914110029